Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05679674 · ClinicalTrials.gov registry record · NA
Stereotactic Body Radiation and Tumor Treating Fields for Locally Advanced Pancreas Cancer
A NA study of Pancreas Cancer and Locally Advanced Pancreatic Adenocarcinoma, sponsored by Baptist Health South Florida.
- Recruiting
- Registry status
- NA
- Development phase
- 48
- Enrollment target
- 1
- Study location
NCT05679674 is a NA study of Pancreas Cancer and Locally Advanced Pancreatic Adenocarcinoma that is actively recruiting participants, run by Baptist Health South Florida. The registered enrollment target is 48 participants, below the 906-participant average among 54 other Pancreas Cancer trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05679674, a NA study of Pancreas Cancer and Locally Advanced Pancreatic Adenocarcinoma, is actively recruiting participants, sponsored by Baptist Health South Florida.
- RECRUITING
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this clinical trial is to determine whether using chemotherapy followed by stereotactic ablative body radiation therapy (SABR) and tumor treating fields (TTF) will slow tumor growth in people with locally advanced pancreas cancer. All participants will receive SABR therapy once per day for five days and use the TTF system for at least 18 hours per day starting on the first day of SABR until the tumor progresses or severe toxicity develops.
Conditions Studied
Interventions
- RADIATION Stereotactic Ablative Body Radiation (SABR)
- DEVICE Tumor Treating Fields (TTF)
Study Locations (1)
Florida
- Miami Cancer Institute at Baptist Health, Inc. - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2023-09-21 |
| Est. Completion | 2027-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05679674
The ClinicalTrials.gov registry entry for NCT05679674 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 906-participant average among 54 other Pancreas Cancer trials with a reported enrollment target (95% lower). The listed sponsor is Baptist Health South Florida, which has 40 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Pancreas Cancer appearing as the primary indexed condition, and to 2 interventions - of which Stereotactic Ablative Body Radiation (SABR) is the first listed.
NCT05679674 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT05679674 about?
NCT05679674 is a clinical study titled "Stereotactic Body Radiation and Tumor Treating Fields for Locally Advanced Pancreas Cancer". The purpose of this clinical trial is to determine whether using chemotherapy followed by stereotactic ablative body radiation therapy (SABR) and tumor treating fields (TTF) will slow tumor growth in people with locally advanced pancreas cancer. All participants will receive SABR therapy once per da...
What is the current status of trial NCT05679674?
This trial is currently recruiting. It is a NA study. The enrollment target is 48 participants. The study started on 2023-09-21. Estimated completion is 2027-06.
What conditions does trial NCT05679674 study?
This clinical trial studies the following conditions: Pancreas Cancer, Locally Advanced Pancreatic Adenocarcinoma, Locally Advanced.
What interventions are being tested in trial NCT05679674?
The interventions under investigation include: Stereotactic Ablative Body Radiation (SABR) (RADIATION), Tumor Treating Fields (TTF) (DEVICE).
Who is sponsoring clinical trial NCT05679674?
This trial is sponsored by Baptist Health South Florida, which has 40 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05679674 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pancreas Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Stereotactic Magnetic Resonance Guided Radiation Therapy
RECRUITING · NA
-
Promoting CT Engagement for Pancreatic Cancer With App
RECRUITING · NA
-
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
RECRUITING · NA
-
Molecular Profile-related Individualized Targeted Therapy in Resected Pancreatic Cancer With High-Risk of Cancer Recurrence
RECRUITING · NA
-
MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRial
RECRUITING · NA
-
EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.